April 2026: CMS delayed the BALANCE model for Medicare Part D indefinitely
With updated clinical guideline recommendations and changes to drug labeling in 20202022, as well as the 2021 approval of finerenonethe only new drug indicated for CKD associated with type 2 diabetes approved in this time periodit is of interest to understand how patterns of SGLT2i and GLP-1 RA use and characteristics of patients prescribed these medications in the US may have changed
Feb 27, 2026 The prevailing narrative around semaglutide and female sexuality goes something like this: lose weight, feel confident, watch your sex drive skyrocket
Need tirzepatide specifically for benefits beyond weight loss
According to a study published in the Journal of Nutrition and Metabolism, foods high in protein, along with fiber and healthy fats, can help stimulate the release of GLP-1
This can make stomach-related symptoms more noticeable at first, especially in the early weeks or after a dose increase